Novo Nordisk stock sinks after 2030 growth plan fails to impress investors Sep 21, 2026 · Cris Tolomia The Danish drugmaker pledged to launch 5 multi-blockbuster drugs by 2030 and grow revenue in line with peers, but investors wanted more Read more »